Lv52
1220 积分 2024-07-22 加入
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study
1个月前
已完结
Optimization of CAR T-cell dose: a debated unresolved issue
1个月前
已完结
Immunophenotype of CAR T-cells and associated apheresis products predicts clinical response in a single-center CD22 CAR T-cell therapy trial in B-cell acute lymphoblastic leukemia
1个月前
已完结
IFN-γ–resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
1个月前
已完结
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target
3个月前
已完结
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
4个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
4个月前
已完结
Should CAR-T cells be used as monotherapy?
4个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
4个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
5个月前
已完结
皖公网安备34019202002308
